Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Ordinary Shares, par value $0.000006 per share
-
Shares outstanding
-
1,091,129,524
-
Total 13F shares
-
14,420,716
-
Share change
-
+7,198,160
-
Total reported value
-
$277,023,896
-
Price per share
-
$19.48
-
Number of holders
-
59
-
Value change
-
+$135,641,492
-
Number of buys
-
48
-
Number of sells
-
12
Institutional Holders of Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share (ZLAB) as of Q3 2018
As of 30 Sep 2018,
Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share (ZLAB) was held by
59 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,420,716 shares.
The largest 10 holders included
Segantii Capital Management Ltd, BAMCO INC /NY/, ORBIMED ADVISORS LLC, PRICE T ROWE ASSOCIATES INC /MD/, Myriad Asset Management Ltd., GILDER GAGNON HOWE & CO LLC, Cormorant Asset Management, LP, Vanguard Group Inc, EcoR1 Capital, LLC, and Rock Springs Capital Management LP.
This page lists
59
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.